Secondary infection of common skin conditions including eczema: antimicrobial prescribing
In development [GID-NG10135] Expected publication date: 02 March 2021
Search results
656 results
-
-
Stye: antimicrobial prescribing
In development [GID-NG10167] Expected publication date: TBC
-
Blepharitis: antimicrobial prescribing
In development [GID-NG10168] Expected publication date: TBC
-
Conjunctivitis: antimicrobial prescribing
In development [GID-NG10166] Expected publication date: TBC
-
Skin abscess: antimicrobial prescribing
In development [GID-NG10163] Expected publication date: TBC
-
Clostridioides difficile infection: antimicrobial prescribing
In development [GID-NG10144] Expected publication date: 23 July 2021
-
Disabled children and young people up to 25 with severe complex needs: integrated service delivery and organisation across health, social care and education
In development [GID-NG10113] Expected publication date: 19 January 2022
-
Safeguarding adults in care homes
In development [GID-NG10107] Expected publication date: 10 February 2021
-
Advocacy services for adults with health and social care needs
In development [GID-NG10156] Expected publication date: TBC
-
Adults with complex needs: social work interventions including assessment, care management and support
In development [GID-NG10145] Expected publication date: 27 April 2022
-
Clostridioides difficile infection: antimicrobial prescribing: draft guidance consultation
We are listening to your views on this antimicrobial prescribing guideline. Comments close 17 February 2021.
-
Chronic kidney disease: assessment and management (update): draft guidance consultation
We are listening to your views on this NICE guideline. Comments close 19 March 2021.
-
Intrapartum care for healthy women and babies (update): draft scope consultation
We are listening to your views on this NICE guideline. Comments close 04 February 2021.
-
Acne Vulgaris: Management: draft guidance consultation
We are listening to your views on this NICE guideline. Comments close 05 February 2021.
-
Advocacy services for adults with health and social care needs: draft scope consultation
We are listening to your views on this NICE guideline. Comments close 22 January 2021.
-
Shared decision making: draft guidance consultation
We are listening to your views on this NICE guideline. Comments close 09 February 2021.
-
Laser lithotripsy for difficult-to-treat bile duct stones: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 12 February 2021.
-
Transvaginal laser therapy for stress urinary incontinence: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 12 February 2021.
-
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex - vivo lung perfusion) for transplantation: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 12 February 2021.
-
Transvaginal laser therapy for urogenital atrophy: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 12 February 2021.
-
Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphoma [ID1589]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 11 February 2021.
-
Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy (CDF Review TA490) [ID1585]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 28 January 2021.
-
Anakinra for treating active Stills disease [ID1463]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 27 January 2021.
-
Ozanimod for treating relapsing-remitting multiple sclerosis [ID1294]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 12 February 2021.
-
Abiraterone for treating newly diagnosed high risk metastatic hormone-naive prostate cancer [ID945]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 16 February 2021.
-
SeHCAT (tauroselcholic [75 selenium] acid) for the investigation of bile acid diarrhoea
In development [GID-DG10039] Expected publication date: 17 November 2021
-
Quantitative faecal immunochemical tests to guide colorectal cancer pathway referral for people with a change in bowel habit or abdominal pain
In development [GID-DG10036] Expected publication date: TBC
-
PlGF-based testing to help diagnose suspected pre-eclampsia (Update of DG23)
In development [GID-DG10040] Expected publication date: 17 November 2021
-
Exploratory economic modelling of SARS-CoV-2 viral detection point of care tests and serology tests
In development [GID-DG10038] Expected publication date: 06 January 2021
-
EarlyCDT Lung for lung cancer risk classification of indeterminate pulmonary nodules
In development [GID-DG10041] Expected publication date: 23 February 2022
-
QAngio XA 3D QFR and CAAS vFFR imaging software for assessing coronary stenosis during invasive coronary angiography
In development [GID-DG10034] Expected publication date: 17 February 2021
-
PredictSURE IBD and IBDX to guide treatment of Crohn's disease
In development [GID-DG10029] Expected publication date: 13 January 2021
-
Integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (update of DG21) (provisional title)
In development [GID-DG10042] Expected publication date: 13 April 2022
-
Tobacco: preventing uptake, promoting quitting and treating dependence (update)
In development [GID-NG10086] Expected publication date: 01 September 2021
-
Atezolizumab monotherapy for untreated PD-L1 positive metastatic non-small-cell lung cancer [ID1678]
In development [GID-TA10587] Expected publication date: 02 June 2021
-
Nivolumab with ipilimumab and chemotherapy for untreated advanced non-small-cell lung cancer [ID1566]
In development [GID-TA10472] Expected publication date: 02 June 2021
-
Epilepsies in children, young people and adults
In development [GID-NG10112] Expected publication date: 16 November 2021
-
Epilepsies in adults: diagnosis and management update (Please see Epilepsies in children, young people and adults)
In development [GID-NG10110] Expected publication date: TBC
-
Osteoarthritis: care and management (update)
In development [GID-NG10127] Expected publication date: 10 August 2022
-
Pernicious anaemia
In development [GID-NG10176] Expected publication date: 23 March 2023
-
Reducing sexually transmitted infections
In development [GID-NG10142] Expected publication date: 09 February 2022
-
Acne Vulgaris: Management
In development [GID-NG10109] Expected publication date: 09 June 2021
-
Multiple sclerosis in adults: management
In development [GID-NG10153] Expected publication date: 20 July 2022
-
Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal
In development [GID-NG10141] Expected publication date: 17 November 2021
-
Antenatal care
In development [GID-NG10096] Expected publication date: 11 August 2021
-
Postnatal care
In development [GID-NG10070] Expected publication date: 07 April 2021
-
Ectopic pregnancy and miscarriage: diagnosis and initial management (update)
In development [GID-NG10173] Expected publication date: TBC
-
Rehabilitation for Chronic Neurological Disorders Including Traumatic Brain Injury
In development [GID-NG10181] Expected publication date: TBC
-
Head injury: assessment and early management
In development [GID-NG10164] Expected publication date: 11 May 2022
-
Type 2 diabetes in adults: management (update)
In development [GID-NG10160] Expected publication date: TBC